Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold

Foy et al describe joint experiences in prioritizing drug proposals in 1997-98 for Christie Hospital NHS Trust in Manchester England.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 1999-02, Vol.318 (7181), p.456-459
Hauptverfasser:	Foy, Robbie, So, June, Rous, Elizabeth, Scarffe, J Howard
Format:	Artikel
Sprache:	eng
Schlagworte:	Ambulatory Care - organization & administration Antineoplastic agents Antineoplastic Agents - economics Antineoplastic Agents - therapeutic use Antineoplastics Biological and medical sciences Breast cancer Cancer Care Facilities Chemotherapy Cost efficiency Cost estimates Drug Costs Education and Debate Evidence-Based Medicine Feedback Funding Health outcomes Health Priorities Hospitalization Hospitals Humans Medical Oncology Medical sciences Neoplasia Oncology Outcome Assessment (Health Care) Pharmacology. Drug treatments Prescription drugs Property trusts Research and development costs United Kingdom
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Foy et al describe joint experiences in prioritizing drug proposals in 1997-98 for Christie Hospital NHS Trust in Manchester England.
ISSN:	0959-8138 0959-8146 1468-5833 1756-1833
DOI:	10.1136/bmj.318.7181.456